Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilar Deals 2025
Biosimilars Deals 2023
Biosimilars Deals 2024
Chris Vindurampulle
Diversity
Helen Macpherson
Intranet
Kimberley Evans
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
Paul Johns
PipCast®
PTE
Trade Marks
Webinars

Samsung Biologics Inks $223m deal with Baxter Healthcare

Jun 18, 2024

Samsung Biologics has renegotiated its manufacturing agreement with Baxter Healthcare, increasing Baxter’s payments to Samsung to over US$223 million through the end of 2034, up from an initial US$15m. The specifics of the products Samsung will manufacture for Baxter remain undisclosed. 

This follows Samsung Biologic’s announcement on 7 February 2024 that it had partnered with Lego Chem Biosciences to develop and manufacture ADCs.